Live attenuated Listeria monocytogenes expressing HIV Gag: Immunogenicity in rhesus monkeys

Vaccine

Volumn 25, Issue 42, 2007, Pages 7470-7479

  Jiang, Shisong ^a,b   Rasmussen, Robert A ^a,b   Nolan, Katrina M ^c   Frankel, Fred R ^c   Lieberman, Judy ^b,d   McClure, Harold M ^e   Williams, Kristina M ^f   Babu, Uma S ^f   Raybourne, Richard B ^f   Strobert, Elizabeth ^e   Ruprecht, Ruth M ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CENTER FOR BLOOD RESEARCH   (United States)

^e EMORY UNIVERSITY   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cellular immunity; d alanine; Listeria monocytogenes; Rhesus monkey; Vaccine

Indexed keywords

DEXTRO ALANINE; GAG PROTEIN; LIVE VACCINE; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL CELL WALL; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG TOLERANCE; GENE REPLICATION; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOGENICITY; LISTERIA MONOCYTOGENES; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RHESUS MONKEY; TH1 CELL; TH2 CELL; WILD TYPE;

ADMINISTRATION, ORAL; AIDS VACCINES; ANIMALS; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENE DELETION; GENES, BACTERIAL; GENES, GAG; HIV ANTIBODIES; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; INJECTIONS, INTRAMUSCULAR; LISTERIA MONOCYTOGENES; LYMPHOCYTE ACTIVATION; MACACA MULATTA; SAFETY; T-LYMPHOCYTES; VACCINES, ATTENUATED;

EID: 34748864967     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.08.013     Document Type: Article

References (55)

1. Baba T.W., Liska V., Hofmann-Lehmann R., Vlasak J., Xu W., Ayehunie S., et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 6 2 (2000) 200-206
2. Ferrantelli F., Hofmann-Lehmann R., Rasmussen R.A., Wang T., Xu W., Li P.L., et al. Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques. AIDS 17 3 (2003) 301-309
3. Ferrantelli F., Rasmussen R.A., Buckley K.A., Li P.L., Wang T., Montefiori D.C., et al. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J Infect Dis 189 12 (2004) 2167-2173
4. Mascola J.R., Lewis M.G., Stiegler G., Harris D., VanCott T.C., Hayes D., et al. Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 73 5 (1999) 4009-4018
5. Parren P.W., and Burton D.R. The antiviral activity of antibodies in vitro and in vivo. Adv Immunol 77 (2001) 195-262
6. Robinson H.L., Montefiori D.C., Johnson R.P., Manson K.H., Kalish M.L., Lifson J.D., et al. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. Nat Med 5 5 (1999) 526-534
7. Rasmussen R.A., Hofmann-Lehman R., Montefiori D.C., Li P.L., Liska V., Vlasak J., et al. DNA prime/protein boost vaccine strategy in neonatal macaques against simian human immunodeficiency virus. J Med Primatol 31 1 (2002) 40-60
8. Pantophlet R., and Burton D.R. GP120: target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24 (2006) 739-769
9. Letvin N.L. Progress toward an HIV vaccine. Annu Rev Med 56 (2005) 213-223
10. Gandhi R.T., and Walker B.D. Immunologic control of HIV-1. Annu Rev Med 53 (2002) 149-172
11. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189 6 (1999) 991-998
12. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283 5403 (1999) 857-860
13. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292 5514 (2001) 69-74
14. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.M., Wagner W., et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290 5491 (2000) 486-492
15. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415 6869 (2002) 331-335
16. Someya K., Ami Y., Nakasone T., Izumi Y., Matsuo K., Horibata S., et al. Induction of positive cellular and humoral immune responses by a prime-boost vaccine encoded with simian immunodeficiency virus gag/pol. J Immunol 176 3 (2006) 1784-1795
17. McMichael A.J. HIV vaccines. Annu Rev Immunol 24 (2006) 227-255
18. Schafer R., Portnoy D.A., Brassell S.A., and Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J Immunol 149 1 (1992) 53-59
19. Pan Z.K., Ikonomidis G., Lazenby A., Pardoll D., and Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat Med 1 5 (1995) 471-477
20. Frankel F.R., Hegde S., Lieberman J., and Paterson Y. Induction of cell-mediated immune responses to human immunodeficiency virus type 1 Gag protein by using Listeria monocytogenes as a live vaccine vector. J Immunol 155 10 (1995) 4775-4782
21. Souders N.C., Verch T., and Paterson Y. In vivo bactofection: Listeria can function as a DNA-cancer vaccine. DNA Cell Biol 25 3 (2006) 142-151
22. Paterson Y., and Maciag P.C. Listeria-based vaccines for cancer treatment. Curr Opin Mol Ther 7 5 (2005) 454-460
23. Yewdell J.W. The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol Rev 207 (2005) 8-18
24. Li P., Gregg J.L., Wang N., Zhou D., O'Donnell P., Blum J.S., et al. Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing. Immunol Rev 207 (2005) 206-217
25. Peters C., and Paterson Y. Enhancing the immunogenicity of bioengineered Listeria monocytogenes by passaging through live animal hosts. Vaccine 21 11-12 (2003) 1187-1194
26. Manohar M., Baumann D.O., Bos N.A., and Cebra J.J. Gut colonization of mice with actA-negative mutant of Listeria monocytogenes can stimulate a humoral mucosal immune response. Infect Immun 69 6 (2001) 3542-3549
27. Angelakopoulos H., Loock K., Sisul D.M., Jensen E.R., Miller J.F., and Hohmann E.L. Safety and shedding of an attenuated strain of Listeria monocytogenes with a deletion of actA/plcB in adult volunteers: a dose escalation study of oral inoculation. Infect Immun 70 7 (2002) 3592-3601
28. Stevens R., Lavoy A., Nordone S., Burkhard M., and Dean G.A. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine. Vaccine 23 12 (2005) 1479-1490
29. Goossens P.L., Milon G., Cossart P., and Saron M.F. Attenuated Listeria monocytogenes as a live vector for induction of CD8+ T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus. Int Immunol 7 5 (1995) 797-805
30. Brockstedt D.G., Giedlin M.A., Leong M.L., Bahjat K.S., Gao Y., Luckett W., et al. Listeria-based cancer vaccines that segregate immunogenicity from toxicity. Proc Natl Acad Sci USA 101 38 (2004) 13832-13837
31. Brockstedt D.G., Bahjat K.S., Giedlin M.A., Liu W., Leong M., Luckett W., et al. Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity. Nat Med 11 8 (2005) 853-860
32. Thompson R.J., Bouwer H.G., Portnoy D.A., and Frankel F.R. Pathogenicity and immunogenicity of a Listeria monocytogenes strain that requires d-alanine for growth. Infect Immun 66 8 (1998) 3552-3561
33. Friedman R.S., Frankel F.R., Xu Z., and Lieberman J. Induction of human immunodeficiency virus (HIV)-specific CD8 T-cell responses by Listeria monocytogenes and a hyperattenuated Listeria strain engineered to express HIV antigens. J Virol 74 21 (2000) 9987-9993
34. Rayevskaya M.V., and Frankel F.R. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes. J Virol 75 6 (2001) 2786-2791
35. Rayevskaya M., Kushnir N., and Frankel F.R. Safety and immunogenicity in neonatal mice of a hyperattenuated Listeria vaccine directed against human immunodeficiency virus. J Virol 76 2 (2002) 918-922
36. Lecuit M., Vandormael-Pournin S., Lefort J., Huerre M., Gounon P., Dupuy C., et al. A transgenic model for listeriosis: role of internalin in crossing the intestinal barrier. Science 292 5522 (2001) 1722-1725
37. Smith K., and Youngman P. Use of a new integrational vector to investigate compartment-specific expression of the Bacillus subtilis spoIIM gene. Biochimie 74 7-8 (1992) 705-711
38. Camilli A., Tilney L.G., and Portnoy D.A. Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol Microbiol 8 1 (1993) 143-157
39. In: Bergmeyer J., and Grassl M. (Eds). Methods of enzymatic analysis, vol. viii, metabolites 3: lipids, amino acids, and related compounds. 3rd ed. (1983), VCH, Weinham
40. Kozlowski P.A., Lynch R.M., Patterson R.R., Cu-Uvin S., Flanigan T.P., and Neutra M.R. Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody. J Acquir Immune Defic Syndr 24 4 (2000) 297-309
41. Kozlowski P.A., Cu-Uvin S., Neutra M.R., and Flanigan T.P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 65 4 (1997) 1387-1394
42. Smith M.A., Takeuchi K., Brackett R.E., McClure H.M., Raybourne R.B., Williams K.M., et al. Nonhuman primate model for Listeria monocytogenes-induced stillbirths. Infect Immun 71 3 (2003) 1574-1579
43. Glomski I.J., Gedde M.M., Tsang A.W., Swanson J.A., and Portnoy D.A. The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells. J Cell Biol 156 6 (2002) 1029-1038
44. Schuchat A., Swaminathan B., and Broome C.V. Epidemiology of human listeriosis. Clin Microbiol Rev 4 2 (1991) 169-183
45. Boyer J.D., Robinson T.M., Maciag P.C., Peng X., Johnson R.S., Pavlakis G., et al. DNA prime Listeria boost induces a cellular immune response to SIV antigens in the rhesus macaque model that is capable of limited suppression of SIV239 viral replication. Virology 333 1 (2005) 88-101
46. Brenchley J.M., Schacker T.W., Ruff L.E., Price D.A., Taylor J.H., Beilman G.J., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200 6 (2004) 749-759
47. Mattapallil J.J., Douek D.C., Hill B., Nishimura Y., Martin M., and Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434 7037 (2005) 1093-1097
48. Belyakov I.M., and Berzofsky J.A. Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 20 3 (2004) 247-253
49. Stevceva L., and Strober W. Mucosal HIV vaccines: where are we now?. Curr HIV Res 2 1 (2004) 1-10
50. Neutra M.R., and Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6 (2006) 148-158
51. McCluskie M.J., Brazolot Millan C.L., Gramzinski R.A., Robinson H.L., Santoro J.C., Fuller J.T., et al. Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates. Mol Med 5 5 (1999) 287-300
52. Feltquate D.M., Heaney S., Webster R.G., and Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158 5 (1997) 2278-2284
53. Bochner B.S., Undem B.J., and Lichtenstein L.M. Immunological aspects of allergic asthma. Annu Rev Immunol 12 (1994) 295-335
54. Weiner H.L. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18 7 (1997) 335-343
55. Kaufmann S.H. Immunity to intracellular bacteria. Annu Rev Immunol 11 (1993) 129-163